#1 Reimbursable NEUROPATHY Program (Small & Large Fibers)

Fall Risk & Neuropathy

Fall Risk & Neuropathy Program – Powered by the Diabetic Neuropathy Device™ (DND)

Our Fall Risk & Neuropathy Program centers on the Diabetic Neuropathy Device™ (DND), the only FDA-registered tool that delivers two reimbursable tests in under three minutes by measuring both small fiber (temperature) and large fiber (vibration) nerve function. Detecting both types of neuropathy is critical, as large fiber loss often goes unnoticed with conventional testing yet drives the majority of diabetes-related amputations and fall injuries.

Key Features of the DND:

Objective Testing: Measures small and large fiber nerve function with unmatched precision.
Early Detection: Identifies neuropathy before complications such as falls, ulcers, and amputations occur.
Rapid & Non-Invasive: FDA-registered, painless test completed in under three minutes.
CMS Reimbursable: Supported by established CPT and HCPCS codes.
Clinical Impact: Gives providers specialist-level insight at the point of care.

By integrating the DND into everyday practice, DTC Chronic Care Clinics® empower providers to offer proactive neuropathy and fall-risk prevention as part of routine care. This turnkey program allows clinics to protect patients’ mobility, independence, and quality of life while capturing new streams of sustainable, reimbursable revenue.

Up to 30% of U.S. Adults 65+ Fall Each Year

Temperature (Small Fiber

"The Device (DND) Replaces Tuning Forks and Monofilaments..."

Kazu Suzuki DPM, Medical Director of the Tower Wound Care Center at the Cedars-Sinai Medical Towers in Los Angeles, CA; Managing Neuropathy And Pain In Wound Care Patients, Podiatry Today; September 2015; 26-27.

Site-Specific Predictive Biomarkers

"Every medical practice should test patients with the DND before referring them to a specialist because it can help identify potential underlying conditions that may require further investigation or treatments." -J. Gonzalez MD, Neurologist

Vibration (Large Fiber)

Fall Risk & Neuropathy

The DND Advantage in Fall Prevention
Falls are one of the most devastating and costly outcomes for patients with diabetes and neuropathy. A single fall can lead to fractures, hospitalization, and permanent loss of independence. What makes these events even more concerning is that large fiber neuropathy—one of the strongest predictors of falls—often goes undetected with conventional methods like tuning forks and monofilaments.

The Diabetic Neuropathy Device™ (DND) is the only FDA-registered tool that delivers two reimbursable tests in under three minutes, measuring both small fiber (temperature) and large fiber (vibration) nerve function. By identifying large fiber loss early, providers can uncover hidden balance dysfunction before it translates into a fall.

How the DND Addresses Fall Risk

Large Fiber Detection: Loss of vibration sensation is directly tied to unsteady gait and fall risk. Early detection enables timely therapy.
Small Fiber Detection: Identifies temperature sensation deficits that often precede ulcers and balance instability.
Objective, Repeatable Results: Quantifiable data supports ongoing therapy, justifies medical necessity, and tracks patient progress.
Specialist-Level Screening in Primary Care: Moves advanced neuropathy and fall-risk diagnostics into the clinic, without needing referrals.

"We regularly use the Diabetic Neuropathy Device™ (DND) to monitor our diabetic patients who are at risk for developing diabetic neuropathy, as well as patients who are already diagnosed with diabetic neuropathy." -C. Soller NP, Endocrinology

"It is imperative that we use our ability to measure quantitatively the different types of defects that occur in the disorder (DN), so the appropriate therapies can be targeted to specific nerve fiber types."

Aaron Vinik, MD, PhD, FCP, MACP, FACE, et al, Endocrinologist, Diabetic Neuropathies, February 5, 2018

Revenue Opportunities

In-Clinic Assessments: Billable neuropathy testing (HCPCS G0245, G0246, G0247; CPT 95923) that also addresses fall risk.
Therapy Pathways: Results support reimbursable therapy codes including gait training, neuromuscular re-education, and biofeedback balance therapy.
Continuity of Care: Ongoing testing and therapy progression can sustain up to a year of reimbursable care, improving patient safety and generating consistent clinic revenue.

The Cost of Untreated Neuropathy and Falls
When neuropathy and fall risk go unaddressed, patients face escalating complications—ulcers, fractures, amputations, cognitive decline, and hospitalization. Each outcome carries a staggering financial burden for CMS, state programs, and commercial payors.

Why It Matters
By detecting neuropathy early with the DND™, providers can intervene sooner, prevent falls, and preserve mobility and independence. At Diabetes Testing Centers™ (DTC) and Chronic Care Programs®, we empower clinics to protect patients with the same level of diagnostics once only available in specialty settings—now accessible, reimbursable, and seamlessly integrated into primary care.

Up to40% of U.S. Adults 75+ Fall Annually

"One of the great advantages of using the DND on our diabetic patients who have started to develop diabetic neuropathy, is that showing them their results, often makes the consequences of not taking care of themselves more realistic." -Dr. Steve, Neuropathy Center

Modern Technology

Early detection of peripheral neuropathy, gait instability, and balance dysfunction is critical to preventing falls, ulcers, and amputations—particularly in patients with diabetes. Our non-invasive in-office tools combine peripheral neuropathy testing with balance and gait assessments using real-time motion analytics and biofeedback to evaluate joint symmetry, gait deviation, motor response, and postural control.

Aligned with the latest American Diabetes Association guidelines for early detection screening of distal symmetric polyneuropathy (DSPN), our technology evaluates both small fiber function (temperature) and large fiber function (vibration)—offering one of the most complete CMS billable assessments available.

By detecting the loss of protective sensation (LOPS) and neuromuscular deficits early, providers can initiate timely, reimbursable diagnostics and therapy interventions that improve mobility, reduce fall risk, and limit opioid exposure.

Don't Change Your Workflow, Just Your Tools!

Two Major Modalities in One Simple-to-Use Handheld Device

Boris Golosarsky, MD MACP FACPI, Podiatry Management, Profiles in Excellence, January 2015

Objectively identify and measure small fiber neuropathy and large fiber neuropathy.

Diabetic Neuropathy Device™ (DND)

The DND is the only FDA-registered neuropathy tool that objectively measures both small fiber (temperature) and large fiber (vibration) nerve function in under three minutes. Unlike outdated tools such as tuning forks or monofilaments, the DND™ delivers precise, repeatable results that are fully Medicare-eligible and reimbursable.

Key applications for your practice include:

Peripheral Neuropathy Testing: Early detection of small and large fiber damage to prevent ulcers, falls, and amputations.
Amputation Prevention: Identifies loss of protective sensation (LOPS) before irreversible complications develop.
Diabetic and Prediabetic Screening: Provides a reliable baseline and ongoing monitoring for high-risk patients.
Objective Documentation: Quantifiable results that strengthen medical necessity, support care plans, and streamline billing.
In-Clinic Efficiency: Non-invasive, staff-friendly, and performed in under three minutes without disrupting workflow.

The DND empowers providers to detect neuropathy earlier, intervene sooner, and keep both care and revenue in-house while protecting patients from preventable complications.

50% of Seniors Who Fall 1x Will Fall Again Within a Year

Book a 15‑minute walkthrough to see how easily DTC programs integrate into your existing workflows.

Simply Better

Page updated

Report abuse